Tissue factor pathway inhibitor (TFPI) is a marker of tumor progression and prognosis in breast cancerM. Tinholt, H. K. M. Vollan,K. K. Sahlberg,R. Karesen,T. Sauer,V Kristensen,A-L Borresen-Dale, P. M. Sandset,N. IversenJOURNAL OF THROMBOSIS AND HAEMOSTASIS(2015)引用 0|浏览11暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要